In Saccharomyces cerevisiae commitment to cell division occurs late in the G1 phase of the cell cycle at a point called Start and requires the activity of the Cdc28 protein kinase and its associated G1 cyclins. The Swi4,6-dependent cell cycle box binding factor, SBF, is important for maximal expression of the G1 cyclin and HO endonuclease genes at Start. The cell cycle regulation of these genes is modulated through an upstream regulatory element termed the SCB (Swi4,6-dependent cell cycle box, CACGAAA), which is dependent on both SWI4 and SWI6. Although binding of Swi4 and Swi6 to SCB sequences has been well characterized in vitro, the binding of SBF in vivo has not been examined. We used in vivo dimethyl sulfate footprinting to examine the occupancy of SCB sequences throughout the cell cycle. We found that binding to SCB sequences occurred in the G1 phase of the cell cycle and was greatly reduced in G2. In the absence of either Swi4 or Swi6, SCB sequences were not occupied at any cell cycle stage. These results suggest that the G1-specific expression of SCB-dependent genes is regulated at the level of DNA binding in vivo.
INTRODUCTION
Passage through Start in Saccharomyces cerevisiae requires the activity of the Cdc28 kinase and the G1 cyclins, Cln1, Cln2 and Cln3 (reviewed in 1). CLN1 and CLN2 are periodically expressed and their protein levels also peak at Start, concurrent with maximal Cdc28 kinase activity (2, 3) . CLN3, however, is expressed at low levels throughout the cell cycle and Cln3-Cdc28 kinase activity is not significantly periodic (2) . Two additional yeast G1 cyclins, PCL1 and PCL2 (formerly called HCS26 and ORFD respectively) are also maximally expressed in G1 (2, (4) (5) (6) . Recent biochemical and genetic data suggest that Pcl1 and Pcl2 complex with another cyclin-dependent kinase, Pho85, to promote cell cycle progression (6, 7) .
Maximal expression of the G1 cyclins, CLN1, CLN2, PCL1 and PCL2, at Start requires the activity of a transcription factor, SBF (SCB binding factor), which binds the repeated upstream regulatory sequence CACGAAA (SCB, Swi4,6-dependent cell cycle box) (reviewed in 8). Multiple copies of this sequence are sufficient to confer cell cycle-regulated transcription upon a reporter gene (9, 10) . SBF is composed of at least two proteins, Swi4 and Swi6 (4, (11) (12) (13) . Swi4 specifically binds the SCB sequence, whereas Swi6 binds indirectly via its interaction with the C-terminus of Swi4 (14) (15) (16) . In the absence of Swi4 or Swi6 or if the SCB sequences are deleted, transcription of HO is abolished (11, 17, 18) and that of the G1 cyclins is greatly reduced (4, (19) (20) (21) (22) . More recently, detailed analysis of CLN2 transcriptional activation has suggested that other non-SCB consensus elements, which may also depend on SWI4, are involved in the periodic transcriptional regulation of CLN2 (21, 22) .
The binding of SBF to SCB sequences has been well characterized in vitro (4, 11, 13, 15) . The upstream regulatory sequence, URS2, of the HO endonuclease gene contains 10 SCB elements (18) . In gel mobility shift assays, promoter sequences from URS2 support SBF complex formation in extracts prepared from cells throughout the cell cycle (the 'L' or 'lower complex') (13; B.J.Andrews, unpublished results). In addition, a minor cell cycle-regulated complex of slightly slower mobility forms on URS2 probes and is Cdc28 dependent (the 'U' or 'upper complex') (13) . Since the appearance of this upper complex occurs slightly after the transcriptional induction of HO and persists following HO repression after Start, its significance with respect to HO transcriptional activation is not clear (13) .
A related transcription factor, the MluI cell cycle box binding factor (MBF, also called DSC1), is composed of Swi6 and the Swi4 homolog Mbp1 (20, 23, 24) . MBF binds an upstream regulatory element (MCB, consensus ACGCGTNA) which is present in the promoters of several genes whose expression is induced at Start, including SWI4, the S phase cyclins CLB5 and CLB6 and other genes involved in DNA synthesis (23) (24) (25) (26) (27) (28) . The MCB element can also direct Start-specific transcription of a heterologous gene and periodic binding of MBF to MCB elements has been observed in vitro (25) . In Schizosaccharomyces pombe the MBF-like complex, DSC1, also binds its target sequence in a cell cycle-regulated manner in vitro (29, 30) . So far the only in vivo observation to suggest that MBF and SBF DNA binding may be cell cycle-regulated is the subcellular localization of the Swi6 protein; Swi6 is nuclear throughout G1 phase and is predominantly cytoplasmic from late G1 until late M phase (13, 48) .
One hypothesis consistent with these data is that the SBF and MBF transcription factors modulate the cell cycle-specific Figure 1 . The promoter sequence of the SCB::lacZ reporter gene used in this study (11) . The direction of the flanking URA3 and lacZ genes are shown by a dashed arrow and the relative orientation of the SCB consensus sequences upstream of the lacZ gene is indicated by solid arrows. The plasmid contains a CYC1 TATA box between the SCB elements and the lacZ transcription start site (41) .
expression of their target genes through periodic changes in their binding activity (8, 31, 32) . In order to examine this question directly we used in vivo dimethyl sulfate (DMS) footprinting to assay for SBF binding throughout the cell cycle. Our in vivo data support the notion that temporal regulation of SBF binding is involved in the G1-specific transcriptional induction of SCBcontaining genes.
MATERIALS AND METHODS

Strains and plasmids
The following yeast strains were used for footprinting experiments: KN699 (=W303a; 2), (Figs 5 and 6 ). The SCB::lacZ plasmid, pBA259, was constructed using synthetic SCB oligonucleotides as described (11) . The plasmid carries five copies of the SCB consensus sequence upstream of a CYC1::lacZ reporter gene in vector YEp24 (Fig. 1) . Yeast strains were transformed using standard techniques (33) .
Cell cycle experiments
Cells were grown to a density of ∼1 × 10 7 cells/ml in complete synthetic medium lacking uracil (SC-URA) (34) . Except where noted, galactose was used as a carbon source and cells were grown and elutriated at room temperature. Elutriations were performed as previously described, with minor modifications (2) . For loading onto the centrifugal elutriator ∼2.0-4.0 × 10 10 cells were pelleted and resuspended in ∼200 ml medium (for flocculant strains, such as swi6 deletion strains, 50 mM EDTA was included in the loading buffer). Cells were loaded at 18 ml/min into a Beckman JC-MI centrifugal elutriator (rotor type JE-5.0) at 2400 r.p.m., pre-equilibrated with the appropriate medium (for most experiments the 'conditioned' medium from the supernatant taken from the pelleted cells was used). Once cells had equilibrated within the rotor the pump speed was gradually increased by 2 ml/min every 3-5 min. The eluate was collected in 200-400 ml increments and cell size and budding were monitored microscopically and using a Coulter channelizer. Typically the first wild-type daughter cells eluted at 30-36 ml/min, whereas for the swi4 and swi6 deleted cells (unbudded cell size greater) the first elution peak occured at >42 ml/min. In particular, for the swi6∆ cells elution required both an increase in pump speed to 46 ml/min and a decrease in rotor speed to 1800 r.p.m. A maximum of 10% of the load volume could be recovered as a homogeneous population of unbudded cells. For the wild-type elutriations a total of five elutriation experiments were performed, using two different strain backgrounds (Figs 2 and 3 and data not shown); for the swi4∆ and swi6∆ strains a total of two elutriations for each strain were performed, using similar genetic backgrounds (Figs 4 and 5 and data not shown).
The synchrony in these experiments was comparable with other published reports (2) , but the large sample volumes needed for DMS footprinting required pooling of G1 cuts from the elutriator. Therefore, in these experiments the percent budded indices are not an indication of the synchrony of the experiment. In addition, percent budded was measured at the time of DMS treatment and not when the sample was first removed from the elutriator. For example, the first elutriator cut from the experiment shown in Figure 2 had a modal cell volume of 17 fl; at the time the sample was DMS treated this modal cell volume had increased to 23 fl.
For each time point ∼100 ml cells were used for DMS footprinting (see below), 10 ml for RNA preparation and 1 ml for FACS analysis. Total RNA was isolated, transferred to nylon membrane and probed as described (35) . The probes used were: a 1.3 kbp XhoI-NcoI fragment of CLN2 (36); a 1.0 kbp NdeI-EcoRI internal fragment of lacZ; a 600 bp EcoRI-HindIII internal fragment of ACT1. FACS (fluorescence-activated cell sorter) analysis was performed using software as described previously (6) .
DMS footprinting
In vivo DMS footprinting was performed using a modification of published protocols (37, 38) . For each sample ∼1 × 10 9 cells were divided in half and pelleted. Half of the sample was rinsed once in 1 M sorbitol and frozen at -20_C for subsequent DNA extraction and in vitro DMS modification. The remaining pellet was resuspended in 1 ml medium (SC-URA with either galactose or raffinose as appropriate). Ten microliters of DMS were added, mixed well and incubated for 5 min at room temperature. To stop the reaction 50 ml cold distilled water was added and the cells were immediately pelleted at 4_C, rinsed with 5 ml 1 M sorbitol and frozen at -20_C.
DNA was prepared from the frozen cell pellet by DTAB extraction as previously described (39) . Following resuspension of the purified DNA the unmodified DNA samples were subjected to in vitro DMS modification as described (40) .
For PCR amplification of the DMS-modified genomic DNA, a primer corresponding to the 3′-end of the URA3 gene in the SCB::lacZ plasmid was used: URA3PCR, 5′-ATTTGAGAAG-ATGCGGCCAGC-3′. DNA was first quantitated by measuring A 260 and ∼20 µg/sample were digested with ApaI (to facilitate primer annealing). To improve loading differences between samples, DNA digestion and quantitation were checked by agarose gel In order to normalize lane-to-lane variations in peak intensity the left-most peak in the plot has been set to an arbitrary value of 1000, as described in Materials and Methods. The sequence of the purine residues within each SCB element is shown at the top. FACS profiles are shown at the right of each sample, as in (B). For clarity two of the five SCB sequences are shown, however, the results were the same for the other protected SCB elements (data not shown). electrophoresis prior to PCR amplification. PCR amplification was carried out under the following conditions: 50 mM KCl, 10 mM Tris-HCl, pH 9.0 (at 25_C), 1% w/v Triton X-100, 0.2 mM each of dATP, TTP, dGTP, dCTP, 0.5 U Taq polymerase (Promega), ∼1 pmol 32 P-5′-end-labeled primer (37, 38) . Amplification was carried out for 18 cycles (1 min at 94_C, 2 min at 56_C, 2 min at 76_C per cycle). The products were phenol/ chloroform extracted, ethanol precipitated and resolved on an 8% w/v denaturing acrylamide gel. Purified SCB::lacZ plasmid was also sequenced using the 32 P-end-labeled URA3PCR primer and was run alongside the genomic DNA samples as a marker. The gel was dried and exposed to Kodak XAR-5 film at -70_C or exposed to a Molecular Dynamics PhosphorImager screen.
Phosphorimager analysis
Gels were exposed on a Molecular Dynamics screen and scanned using a Molecular Dynamics PhosphorImager and Imagequant (version 3.1) software. To obtain the graphical representation of the footprints shown in Figures 2, 4 , 5 and 6 a line was drawn vertically through the center of the lane and the intensity at each point on the line was integrated by percent area to generate a linear plot of band intensities. To compare the pattern obtained by in vitro DMS modification with the pattern obtained by in vivo DMS modification samples were normalized for slight differences in DNA quantitation, PCR amplification and gel loading. First, a 'background' line was drawn between the sample lanes (where no DNA was loaded) and the values at each point on this line were subtracted from the values at each equivalent point on the sample line. Second, a band was chosen near the SCB sequences that did not appear to be protected by DMS modification in any experiments and was assigned an arbitrary value of 1000. For example, the raw phosphorimager values for each peak normalized to 1000 in the experiment shown in Figure 2D Figure 6 are taken from the same data as shown in Figures 2, 4 and 5. Only the bottom two SCB sequences are shown for clarity. No consistent protection of 5′ or 3′ flanking sequences was apparent in the phosphorimager plots (data not shown). Several other bands, outside the SCB sequences, were also tested as normalization standards and gave similar results (data not shown). The band closest to the SCB sequences was chosen for the final presentation of the data for the following reason. Since Taq polymerase stops at modified purines, there will be a gradient of more intense radioactive bands from the bottom to the top of the gel (the more modified the DNA, the shorter the products). We found that this 'gradient' differed slightly between the in vitro and in vivo DMS-modified samples (data not shown). Therefore, the farther the normalization band is from the region of interest, the greater the skewing of results toward either the in vitro or in vivo pattern. This sample-to-sample variation can occur between any modified sample, thus we also chose the SCB-proximal band to compare the in vivo DMS patterns shown in Figure 6 .
RESULTS
Use of a SCB-dependent lacZ reporter plasmid for in vivo DMS footprinting
In order to examine binding to SCB sequences in vivo, a high copy number plasmid containing five SCB consensus sites inserted upstream of lacZ was introduced into yeast cells (Fig. 1) . Like chromosomal SBF targets, the tandem SCB elements serve as an orientation-independent enhancer to confer cell cycle regulation of lacZ transcription, with maximal expression at Start (9,10). Expression of lacZ absolutely depends on the SCB promoter element and is not transcribed in the absence of Swi4 or Swi6 (11, 41) . Thus high copy expression of the SCB::lacZ gene parallels expression of a genomic SCB-dependent promoter, such as HO, in both its regulation and transcriptional induction.
Dimethyl sulfate was used for in vivo footprinting in order to minimize the perturbation of cells, since treatment times are short (4-5 min) and can be carried out on intact cells at room temperature. Methylated purines were visualized after one-sided PCR amplification using Taq polymerase (37) . As a control for the DMS modification pattern in the absence of bound proteins, DNA was isolated from each sample and then subjected to DMS modification in vitro, followed by PCR amplification (see Materials and Methods).
Binding of SCB sequences in an asynchronous yeast cell population
A wild-type yeast strain carrying the SCB::lacZ plasmid was examined for SCB footprinting during exponential growth. DMS modification of an asynchronous population showed weak protection of the SCB sequences compared with the same DNA sample after deproteinization and in vitro DMS modification ( Fig. 2A, lanes 1 and 2 , and data not shown). In particular, slight protection was observed over the dA residues on the purine-rich strand (5′-CACGAAA-3′) of each SCB sequence ( Fig. 2A) . There was no significant protection of the pyrimidine-rich strand in vivo (5′-GTGCTTT-3′; Fig. 2A , lane 2, and data not shown). The weak protection over the dA residues in the SCB sequences was confirmed by phosphorimager analysis of the in vivo DMS-treated sample compared with in vitro modified DNA from the same sample (Fig. 2D, 'log' ).
G1 phase periodicity of SCB protection
Since asynchronous cultures contain cells in both G1 and G2 (by FACS analysis; Fig. 2C ), we sought to enrich the SCB footprint by analysis of a homogeneous G1 cell population. G1 daughter cells were obtained by centrifugal elutriation and re-inoculated into conditioned medium. This method minimizes any perturbation of physiological state, since it does not involve temperature shift, media shift or drug addition. Progression of the re-inoculated culture was monitored throughout the cell cycle by cell size, FACS, percentage budded cells and Northern analysis (Fig. 2B and C) .
In contrast to the asynchronous population, the homogeneous G1 daughter culture showed significant protection over the SCB sequences in the lacZ promoter ( Fig. 2A, lanes 4 and 5) . Protection of the dA residues within each SCB was more pronounced than in asynchronous cultures (Fig. 2A, compare  lanes 2, 4 and 5 ). In addition, slight protection over the dG residue on the purine-rich strand was also observed (Fig. 2A, lanes 4 and  5) . Some residues between the SCB sequences were also slightly protected in G1 cells on the purine-rich strand (Fig. 2A) . The dG residues on the pyrimidine-rich strand of the SCB were only weakly footprinted (Fig. 2A, lane 3 , and data not shown). As cells progressed into G2 the SCB footprint over these sequences was diminished to a level similar to that observed in the asynchronous population ( Fig. 2A, lanes 6 and 7) .
Due to technical limitations on the DNA yields of elutriated samples, some of the lanes within one experiment were under- loaded relative to others (Fig. 2A, compare lanes 2 and 4) . For this reason, DMS modification was also carried out on deproteinized DNA for each sample and normalized to the in vivo DMS modification pattern using a phosphorimager (see Materials and Methods). For example, phosphorimager analysis of the weak protection apparent in the residues below the SCB sequences (close to URA3; Fig. 2A, lanes 4 and 5) showed that this protection was not cell cycle specific (Materials and Methods and data not shown). However, the phosphorimager plots did confirm the weak protection over the dA residues in the SCB for the asynchronous cell population (Fig. 2D, 'log' ). In the G1 samples, strong protection over dA and dG residues of the SCB was also observed after phosphorimager normalization, including weak protection over two adjacent purine residues between the SCBs (Fig. 2D, panels 1 and 2 ). As cells progressed into G2 this protection declined significantly (Fig. 2D, panel 4) .
Northern analysis showed that the peak of lacZ transcription in G1 coincided with or followed closely after footprinting over the SCB region (Fig. 2B and C) . The induction of lacZ transcription showed parallel kinetics to another SCB-dependent gene, CLN2 (Fig. 2C) . The lacZ transcript peaked slightly later than CLN2 and its level persisted compared with CLN2 mRNA (Fig. 2C) , possibly due to differences in mRNA half-life. The large samples required within each experiment did not allow us to follow the transcripts further into the cell cycle. However, similar kinetics of lacZ and CLN2 induction were also observed in another elutriation (data not shown).
A similar pattern of DMS protection was observed in all G1 cell populations, whether in early or late G1 (Fig. 3) . For example, the footprinting pattern in small daughter cells (11 fl), although of weak intensity due to the small sample size, did not significantly differ from the pattern in larger G1 cells (Fig. 3, lanes 2 and 4-7) . One minor difference observed was that protection of the dG residue of the SCB was more pronounced in cells in mid-G1 compared with early G1 or asynchronous cultures (Fig. 3) . As cells entered G2, protection over the SCB sequences was diminished (Fig. 3, lanes 9 and 10) . For example, cells that were 75% budded showed almost no footprint as compared with an in vitro DMS-modified sample (Fig. 3, lanes 10 and 11) .
Requirement of both SWI4 and SWI6 for SCB binding in vivo
To determine whether the in vivo SCB footprint was due to SBF or some other DNA binding factor we examined protection of SCB sequences throughout the cell cycle in strains that were deleted of SWI4 or SWI6. SWI4 and SWI6 disruption strains were each elutriated and examined for DMS footprinting in vivo. In Figure 5 . In vivo DMS footprinting of SCB sequences in a swi6 deletion strain. This strain is isogenic to the wild-type strain shown in Figure 3 contrast to wild-type cells, no significant footprint over the SCB sequences was observed in either deletion strain at any stage in the cell cycle (Figs 4A and 5A ). Northern analysis of elutriated cells from both SWI4 and SWI6 deletion strains showed that lacZ was not transcribed at any stage of the cell cycle (Figs 4B and C and 5B and C). However, as has been seen previously, low levels of CLN2 were still expressed in the absence of SWI4 or SWI6 (Figs 4B and C and 5B and C; 21, 22) .
Phosphorimager analysis was performed on the in vivo footprinting patterns for both the swi4∆ and swi6∆ elutriation experiments ( Figs 4D and 5D) . In swi4∆ cells no detectable footprint was observed in either the asynchronous population, G1 or G2 cells (Fig. 4D) . In swi6∆ cells no detectable footprint was seen in any elutriated sample (Fig. 5D) . The very weak footprint observed over the dA residues in the swi6∆ asynchronous cell population (Fig. 2D, panel 1) was not observed in other experiments or in the purified G1 or G2 samples from this experiment (Fig. 5D, panels 2-4 , and data not shown).
We also directly compared the in vivo DMS modification patterns for wild-type, swi4∆ and swi6∆ cells between G1 cells and cells that had entered G2 (Fig. 6) . In wild-type cells there was a clear protection of SCB sequences in the G1 cells compared with cells that had progressed through Start, both visually and by phosphorimager analysis (Fig. 6A) . In swi4 or swi6 deletion strains, however, there was no detectable difference between the in vivo DMS modification patterns in G1 cells compared with cells later in the cell cycle ( Fig. 6B and C) .
DISCUSSION
Binding to tandem SCB sequences and cell cycle regulation
We chose centrifugal elutriation and DMS footprinting to analyze the cell cycle regulation of SCB binding in vivo. We found that footprinting over SCB sequences was specifically detected in G1 daughter cells purified by centrifugal elutriation and was not detected in cells that had progressed into G2. Although the least physiologically perturbing, cell sampling by elutriation usually precludes analysis beyond one cell cycle. In contrast, other methods involving cell cycle arrest and release can typically retain synchrony for two cell cycles. However, we found only a weak footprint at SCB sequences in wild-type cells using several methods of cell cycle arrest, including α-factor, nocodazole and temperature-sensitive cdc28 alleles (data not shown).
The technical difficulty of obtaining enough DNA from each cell cycle sample for DMS footprinting also necessitated the use of a high copy number plasmid. For example, in these experiments Figure 2A were directly compared. The plots are normalized to the same SCB-proximal band as shown in Figure 2A . The thick line represents the scan of the G1 cells (see Fig. 2A, lane 5) , the thin line that of cells entering G2 (Fig. 2A, lane 6 single copy genomic footprinting would require ∼1 l of purified, elutriated cells for each cell cycle time point. While ligation-mediated PCR (LM-PCR) analysis has been successfully used in yeast for in vivo footprinting of single copy genomic sequences (40), we were unable to detect an SCB footprint with LM-PCR (data not shown). It is possible that the number of protected sequences was too low to be detected after ligation and PCR amplification. High copy number plasmids were also used in initial studies of cell cycle-regulated binding of the origin recognition complex, ORC, at ARS1 (42, 43) .
The specificity of SBF binding in vivo
Using in vivo DMS modification we observed protection of several purines in the SCB promoter during G1. Most pronounced was protection of the dA residues of the SCB, CACGAAA, whereas the only remaining purine, dG, was weakly protected in G1. In vitro the carboxymethylation interference pattern of the N-terminus of Swi4 bound to the CLN2 SCB shows a very similar footprinting pattern (15) . Four of the five SCB sequences on one strand were all protected in G1, including two purine residues between the SCB sequences. Previous studies have suggested that SBF can bind cooperatively to tandem SCB sequences (11) , however, since the DMS footprinting pattern represents a population of DNA molecules, we cannot determine SBF occupancy on any particular SCB element.
The absence of SCB binding in a swi4 deletion strain supports the hypothesis that it is SBF that is bound to the promoter and not some other DNA binding factor, such as MBF. MBF complexes contain Swi6 and the Swi4 homolog Mbp1 (reviewed in 8). In vitro Mbp1 and Swi4 can bind to the same sequences and binding of SBF to the SCB can be specifically competed by MCB sequences (24, 25) . Since Mbp1 is still present in the SWI4 deletion strain, we presume that the specificity of binding of MBF and SBF is more tightly regulated in vivo and that MBF cannot substitute for binding to the SCB sequences in the absence of Swi4. A recently identified factor, SCELA (S.cerevisiae E2F-like activity), can efficiently bind SCB sites in vitro (44) . Our results suggest that SCELA does not detectably bind SCB sequences in vivo.
We have found that Swi4 protein alone cannot bind SCB sequences in vivo. In vitro the N-terminal DNA binding domain of Swi4 is sufficient to footprint an SCB consensus sequence in the CLN2 promoter (15) . However, in our experiments protection of SCB sequences was not detected in swi6∆ cells. A regulatory mechanism may prevent binding of Swi4 alone to the SCB sequences in G1. Since Swi6 protein is found predominantly in the nucleus only in G1, it is possible that Swi6 nuclear localization is important for SBF complex formation (13, 48) .
SCB binding in vivo may not be sufficient for G1 transcription
Although the SCB sequences upstream of the G1 cyclins CLN1 and CLN2 are required for their maximum expression at Start, recent studies have indicated that cell cycle regulation of these genes is not strictly dependent on upstream SCB sites (21, 22) . In particular, deletion of the SCB and MCB elements upstream of CLN2 does not completely abolish its periodic expression (21, 22) . Similarly, deletion of three upstream MCB elements does not abolish the G1 periodicity of SWI4 mRNA (26) . Thus SBF and MBF may be only partially responsible for the amplification of G1 cyclin levels at Start. We have shown a correlation between the timing of SCB binding in vivo and transcriptional activation of a reporter gene that is completely SBF dependent. Whether the role of SBF is to help initiate transcription or amplify it, binding of SCB sequences at the time of CLN transcriptional induction is consistent with a role for SBF binding in the initial induction of SCB target genes in early G1. However, since SCB sequences were also occupied in early G1, prior to the peak in SCB-driven transcription, it is possible that a second event after SCB binding may be required for transcriptional induction.
The regulation of SCB binding in vivo
The fact that SCB binding is G1 specific raises the interesting question as to what activates the binding of SBF in early G1 and what events must occur, if any, after SBF binding to activate transcription. Several studies have shown that transcriptional activation of the G1 cyclins and HO are dependent on active Cdc28 kinase (reviewed in 8). In particular, recent experiments show that SBF-and MBF-driven transcription of the G1 cyclins is activated by the Cln3-Cdc28 kinase (45, 46) . Our finding that SCB binding occurs specifically in G1 suggests that the DNA binding activity of SBF may be a direct target for such regulation. Other studies have suggested an additional role for Cdc28 in regulating SBF activity. In particular, it has previously been shown that Clb2-Cdc28 kinase is required for repression of cyclin expression in G2 and that Clb2 can bind Swi4 (47) . These results suggest that Clb2-Cdc28 may negatively regulate G1 cyclin expression by direct interaction with Swi4. Our finding that SCB sites are not significantly occupied in G2 is consistent with the possibility that Swi4 regulation by Clb2-Cdc28 kinase may occur at the level of SCB binding in vivo.
Note added in proof
A second study has revealed cell cycle-regulated binding to SCB sequences in vivo. Koch et al. find G1-specific binding of SCB sequences within the CLN2 promoter in vivo [Koch,C., Schleiffer,A., Ammerer,G. and Nasmyth,K. (1995) Genes Dev. in press].
